Last Updated : February 6, 2017
When patients are hospitalized, their blood glucose control may be suboptimal because oral medications are often stopped on admission. High blood sugar levels, or hyperglycemia, are common among hospitalized patients and are linked to several complications, including increased morbidity, mortality, and hospital stay. In addition, low blood sugar levels, or hypoglycemia, are serious risks associated with insulin therapy and can potentially lead to arrhythmias and other cardiac events. Hospital management of diabetes focuses on the prevention of shortterm complications of diabetes, such as the symptoms of hyperglycemia and hypoglycemia, as well as prevention of infections and surgical complications.
Insulin is commonly recommended for controlling blood glucose during a hospital stay. Two methods of insulin administration in the hospital setting are currently in use: sliding-scale insulin therapy and basal-bolus insulin therapy. Sliding-scale insulin therapy consists of giving patients regular or rapid-acting insulin five to 30 minutes before meals, with doses based on before-meal measurements of capillary blood glucose. In basal-bolus insulin therapy, patients are given a basal (long-acting) insulin once or twice daily, a nutritional (short- or rapid-acting) insulin before meals, and a correctional (short- or rapid-acting) insulin for any unexpected before-meal hyperglycemia. Hyperglycemia in hospitalized patients is traditionally controlled using sliding-scale insulin therapy. However, basal-bolus insulin therapy more closely imitates the body’s normal release of insulin, and is the recommended method of insulin administration today.
Better glucose control with insulin for both type 1 and type 2 diabetes may improve clinical outcomes and prevent complications in hospitals. A review of the clinical effectiveness and cost-effectiveness of basalbolus insulin therapy compared with sliding-scale insulin therapy for adult patients with type 1 or type 2 diabetes will help to inform decisions regarding insulin therapy in the acute care hospital setting.
A limited literature search was conducted of key resources, and titles and abstracts of the retrieved publications were reviewed. Full-text publications were evaluated for final article selection according to predetermined selection criteria (population, intervention, comparator, outcomes, and study designs).
The literature search identified 474 citations, 19 of which were deemed potentially relevant. Of these articles, four met the criteria for inclusion in this review — one systematic review and three primary studies.